Lieberman, Jeffrey A <br/><br/>
A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia.  [electronic resource] 

 -  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology  May 2013 
 - 968-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1740-634X 
<br/><br/><label>Standard No.: </label>10.1038/npp.2012.259  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antipsychotic Agents--therapeutic use<br/>Benzofurans--therapeutic use<br/>Female<br/>Humans<br/>India--epidemiology<br/>Male<br/>Middle Aged<br/>Nicotinic Agonists--therapeutic use<br/>Nootropic Agents--therapeutic use<br/>Quinuclidines--therapeutic use<br/>Schizophrenia--drug therapy<br/>Schizophrenic Psychology<br/>United States--epidemiology<br/>Young Adult<br/>alpha7 Nicotinic Acetylcholine Receptor--physiology